Literature DB >> 12729892

Preliminary characterisation of the promoter of the human p22(phox) gene: identification of a new polymorphism associated with hypertension.

María U Moreno1, Gorka San José, Josune Orbe, José A Páramo, Oscar Beloqui, Javier Díez, Guillermo Zalba.   

Abstract

The p22(phox) subunit is an essential protein in the activation of NAD(P)H oxidase. Here we report the preliminary characterisation of the human p22(phox) gene promoter. The p22(phox) promoter contains TATA and CCAC boxes and Sp1, gamma-interferon and nuclear factor kappaB sites. We screened for mutations in the p22(phox) promoter and identified a new polymorphism, localised at position -930 from the ATG codon, which was associated with hypertension. Mutagenesis experiments showed that the G allele had higher promoter activity than the A allele. These results suggest that the -930(A/G) polymorphism in the p22(phox) promoter may be a novel genetic marker associated with hypertension.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12729892     DOI: 10.1016/s0014-5793(03)00331-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  21 in total

Review 1.  Oxidative stress and hypertension: current concepts.

Authors:  Ana M Briones; Rhian M Touyz
Journal:  Curr Hypertens Rep       Date:  2010-04       Impact factor: 5.369

2.  Haplotype analysis of NAD(P)H oxidase p22 phox polymorphisms in end-stage renal disease.

Authors:  Kent Doi; Eisei Noiri; Akihide Nakao; Toshiro Fujita; Shuzo Kobayashi; Katsushi Tokunaga
Journal:  J Hum Genet       Date:  2005-10-08       Impact factor: 3.172

Review 3.  The mosaic theory revisited: common molecular mechanisms coordinating diverse organ and cellular events in hypertension.

Authors:  David G Harrison
Journal:  J Am Soc Hypertens       Date:  2013 Jan-Feb

Review 4.  Reactive oxygen species in vascular biology: implications in hypertension.

Authors:  R M Touyz; E L Schiffrin
Journal:  Histochem Cell Biol       Date:  2004-08-26       Impact factor: 4.304

5.  G allele of the -930A>G polymorphism of the CYBA gene is associated with insulin resistance in obese subjects.

Authors:  M C Ochoa; C Razquin; G Zalba; M A Martínez-González; J A Martínez; A Marti
Journal:  J Physiol Biochem       Date:  2008-06       Impact factor: 4.158

6.  Association of NADPH oxidase p22phox gene C242T, A640G and -930A/G polymorphisms with primary knee osteoarthritis in the Greek population.

Authors:  Panagiotis Lepetsos; Andreas Pampanos; Stergios Lallos; Emmanouil Kanavakis; Dimitrios Korres; Athanasios G Papavassiliou; Nicolaos Efstathopoulos
Journal:  Mol Biol Rep       Date:  2013-08-07       Impact factor: 2.316

Review 7.  CYBA encoding p22(phox), the cytochrome b558 alpha polypeptide: gene structure, expression, role and physiopathology.

Authors:  Marie José Stasia
Journal:  Gene       Date:  2016-04-02       Impact factor: 3.688

8.  CYBA Gene Polymorphisms and Adverse Outcomes in Acute Kidney Injury: A Prospective Cohort Study.

Authors:  Mary C Perianayagam; Hocine Tighiouart; Caroline M Nievergelt; Daniel T O'Connor; Orfeas Liangos; Bertrand L Jaber
Journal:  Nephron Extra       Date:  2011-10-21

9.  Association between NADPH oxidase p22(phox) C242T polymorphism and ischemic cerebrovascular disease: a meta-analysis.

Authors:  Bing-Hu Li; Li-Li Zhang; Bei-Bei Zhang; Yan-Wei Yin; Li-Meng Dai; Yan Pi; Lu Guo; Chang-Yue Gao; Chuan-Qin Fang; Jing-Zhou Wang; Jing-Cheng Li
Journal:  PLoS One       Date:  2013-02-11       Impact factor: 3.240

Review 10.  Genetics and immunopathology of chronic granulomatous disease.

Authors:  Marie José Stasia; Xing Jun Li
Journal:  Semin Immunopathol       Date:  2008-05-29       Impact factor: 11.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.